Insufficient scRNA-seq data for expression of TOE1 at single-cell level.
Insufficient scRNA-seq data for expression of TOE1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 617.34 | 1445 / 1445 | 100% | 16.07 | 183 / 183 |
ovary | 100% | 792.54 | 180 / 180 | 100% | 18.86 | 430 / 430 |
skin | 100% | 668.28 | 1809 / 1809 | 100% | 22.02 | 472 / 472 |
uterus | 100% | 835.14 | 170 / 170 | 100% | 20.62 | 459 / 459 |
intestine | 100% | 793.93 | 966 / 966 | 100% | 20.61 | 526 / 527 |
prostate | 100% | 918.91 | 245 / 245 | 100% | 14.20 | 501 / 502 |
breast | 100% | 735.32 | 459 / 459 | 100% | 17.41 | 1115 / 1118 |
thymus | 100% | 1065.14 | 653 / 653 | 100% | 26.17 | 603 / 605 |
stomach | 99% | 603.29 | 357 / 359 | 100% | 19.46 | 286 / 286 |
bladder | 100% | 745.67 | 21 / 21 | 99% | 17.51 | 500 / 504 |
lung | 99% | 532.02 | 574 / 578 | 100% | 14.04 | 1153 / 1155 |
brain | 99% | 422.49 | 2610 / 2642 | 100% | 15.11 | 705 / 705 |
liver | 100% | 430.55 | 226 / 226 | 99% | 9.41 | 400 / 406 |
kidney | 100% | 585.64 | 89 / 89 | 97% | 10.46 | 874 / 901 |
adrenal gland | 100% | 661.28 | 258 / 258 | 97% | 12.11 | 223 / 230 |
pancreas | 97% | 302.04 | 319 / 328 | 99% | 14.29 | 177 / 178 |
adipose | 100% | 670.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 564.85 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.50 | 29 / 29 |
spleen | 100% | 1098.64 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.52 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 17.73 | 79 / 80 |
heart | 98% | 315.80 | 848 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 207.81 | 734 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 488.41 | 830 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034472 | Biological process | snRNA 3'-end processing |
GO_0015030 | Cellular component | Cajal body |
GO_0016607 | Cellular component | nuclear speck |
GO_0005730 | Cellular component | nucleolus |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0000175 | Molecular function | 3'-5'-RNA exonuclease activity |
GO_0017069 | Molecular function | snRNA binding |
GO_0004535 | Molecular function | poly(A)-specific ribonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | TOE1 |
Protein name | Target of EGR1 protein 1 |
Synonyms | |
Description | FUNCTION: Inhibits cell growth rate and cell cycle. Induces CDKN1A expression as well as TGF-beta expression. Mediates the inhibitory growth effect of EGR1. Involved in the maturation of snRNAs and snRNA 3'-tail processing . . |
Accessions | Q96GM8 ENST00000372090.6 [Q96GM8-1] |